Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Effects of EHD2 interference on migration of esophageal squamous cell carcinoma.

Li M, Yang X, Zhang J, Shi H, Hang Q, Huang X, Liu G, Zhu J, He S, Wang H.

Med Oncol. 2013 Mar;30(1):396. doi: 10.1007/s12032-012-0396-4. Epub 2013 Jan 25.

2.

Low expression of cyclic AMP response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma.

Wang Y, Zhou S, Yang X, Shi H, Li M, Xue Q, Huang X, Wang X, Wang H, Zhang J.

Tumour Biol. 2013 Dec;34(6):3649-57. doi: 10.1007/s13277-013-0946-1. Epub 2013 Aug 9.

PMID:
23929392
3.

The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

Kim SH, Kim JH, Yu EJ, Lee KW, Park CK.

Histol Histopathol. 2012 Jan;27(1):49-58.

PMID:
22127596
4.

Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.

Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, Shimada Y.

Clin Cancer Res. 2005 Apr 1;11(7):2597-605.

5.

BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.

Xu G, Tang S, Yang J, Chen K, Kang J, Zhao G, Feng F, Yang X, Zhao L, Lu Q, Sun L, Hong L, Gong T, Zhang H.

Dig Dis Sci. 2013 Jul;58(7):1871-9. doi: 10.1007/s10620-013-2611-3. Epub 2013 Mar 17. Erratum in: Dig Dis Sci. 2013 Aug;58(8):2429-30.

PMID:
23504348
6.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
7.

The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.

Zhang JY, Bai CY, Bai YQ, Zhang JY, Wu ZY, Wang SH, Xu XE, Wu JY, Zhu Y, Rui Y, Li EM, Xu LY.

Hum Pathol. 2014 Oct;45(10):2014-22. doi: 10.1016/j.humpath.2014.05.014. Epub 2014 Jun 12.

PMID:
25090917
8.

Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion.

Nakashima Y, Yoshinaga K, Kitao H, Ando K, Kimura Y, Saeki H, Oki E, Morita M, Kakeji Y, Hirahashi M, Oda Y, Maehara Y.

Cancer Sci. 2013 Dec;104(12):1718-25. doi: 10.1111/cas.12286. Epub 2013 Oct 22.

9.

Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.

Zhu J, Ji L, Zhang J, Yang L, Guan C, Wang Y, Zhu J, Liang L, Ni R.

Tumour Biol. 2014 Oct;35(10):10275-85. doi: 10.1007/s13277-014-2305-2. Epub 2014 Jul 18.

PMID:
25034528
10.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
11.

Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.

Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Mori M, Doki Y.

Oncol Rep. 2012 Apr;27(4):940-6. doi: 10.3892/or.2011.1607. Epub 2011 Dec 22.

12.

[Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].

Zhang Y, Liu YP, Du K, Wang H, Wang XL.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):594-8. Chinese.

PMID:
22325219
13.

The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.

Wang WS, Zhong HJ, Xiao DW, Huang X, Liao LD, Xie ZF, Xu XE, Shen ZY, Xu LY, Li EM.

Dis Esophagus. 2010 Aug;23(6):512-21. doi: 10.1111/j.1442-2050.2009.01035.x. Epub 2010 Jan 20.

PMID:
20095995
14.

Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.

Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ.

Med Oncol. 2012 Mar;29(1):151-60. doi: 10.1007/s12032-010-9816-5. Epub 2011 Jan 23.

PMID:
21259057
15.

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Cancer Sci. 2013 Jan;104(1):48-54. doi: 10.1111/cas.12030. Epub 2012 Nov 8.

16.

Down-regulated γ-catenin expression is associated with tumor aggressiveness in esophageal cancer.

Fang WK, Liao LD, Gu W, Chen B, Wu ZY, Wu JY, Shen J, Xu LY, Li EM.

World J Gastroenterol. 2014 May 21;20(19):5839-48. doi: 10.3748/wjg.v20.i19.5839.

17.

Low expression of N-myc downstream-regulated gene 2 in oesophageal squamous cell carcinoma correlates with a poor prognosis.

Cao W, Yu G, Lu Q, Zhang J.

BMC Cancer. 2013 Jun 24;13:305. doi: 10.1186/1471-2407-13-305.

18.
19.

High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.

Hao CL, Li Y, Yang HX, Luo RZ, Zhang Y, Zhang MF, Cheng YF, Wang X.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4213-21. eCollection 2014.

20.

Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Zhu S, Li Y, Mi L, Zhang Y, Zhang L, Gong L, Han X, Yao L, Lan M, Chen Z, Zhang W.

Dig Dis Sci. 2011 Dec;56(12):3569-76. doi: 10.1007/s10620-011-1812-x. Epub 2011 Jul 26.

PMID:
21789540
Items per page

Supplemental Content

Write to the Help Desk